Literature DB >> 22661179

Antinociception by metoclopramide, ketamine and their combinations in mice.

Fouad K Mohammad1, Banan Kh Al-Baggou, Ahmed S Naser.   

Abstract

BACKGROUND: Metoclopramide is a centrally acting antiemetic and ketamine is a general anesthetic used with sedatives, tranquilizers and analgesics. Metoclopramide has analgesic effects and its combination with ketamine causes sedation and hypnosis. The contribution of metoclopramide to the analgesic effect of ketamine is not known. The purpose of the present study was to explore the analgesic effects of metoclopramide and ketamine alone or in combination in mice.
METHODS: The up-and-down method was used to determine the median effective analgesic dosages (ED(50)s) of metoclopramide and ketamine administered intraperitoneally (ip) either alone or concomitantly in male albino Swiss mice. Analgesia was measured by using a hot plate. The ED(50)s of both drugs were analyzed isobolographically to determine the type of interaction between them. The analgesic effect of metoclopramide-ketamine combination (62.3 and 4.3 mg/kg, ip) was also monitored by the hot plate and acetic acid writhing methods.
RESULTS: The analgesic ED(50)s for metoclopramide and ketamine in mice were 30.15 and 2.15 mg/kg, ip, respectively. Concomitant administration of the drugs reduced their ED(50)s to 10.17 and 0.68 mg/kg, ip, respectively. Isobolographic analysis of these ED(50)s for both drugs revealed synergistic analgesic effect. Further, the combination of the drugs was effective analgesic as seen by the hot plate test and by another analgesic test paradigm, the acetic acid-induced writhings in mice.
CONCLUSIONS: The data suggest that the combination of metoclopramide and ketamine synergistically controls acute pain in mice. This combination could be used clinically for restraint and minor surgical interventions in mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661179     DOI: 10.1016/s1734-1140(12)70768-5

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  2 in total

1.  Betulinic acid alleviates dextran sulfate sodium-induced colitis and visceral pain in mice.

Authors:  Jaspreet Kalra; Madhu Cholenahalli Lingaraju; Karikalan Mathesh; Dhirendra Kumar; Subhashree Parida; Thakur Uttam Singh; Anil Kumar Sharma; Dinesh Kumar; Surendra Kumar Tandan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-26       Impact factor: 3.000

Review 2.  Anti-Inflammatory Activities of Betulinic Acid: A Review.

Authors:  José Fernando Oliveira-Costa; Cássio Santana Meira; Maria Vitória Gomes das Neves; Bruna Padilha Zurita Claro Dos Reis; Milena Botelho Pereira Soares
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.